Literature DB >> 14668775

The suitability of gamma camera coincidence systems for nitrogen 13-labeled ammonia myocardial perfusion imaging: a quantitative comparison with full-ring PET.

Fergus I McKiddie1, Howard G Gemmell, E Joyce Davidson, Andrew Welch, Mohaned Egred.   

Abstract

BACKGROUND: The aim of this study was to examine the quality of nitrogen 13-labeled ammonia (NH(3)) perfusion data from coincidence-capable gamma camera positron emission tomography (GC-PET) systems compared with that from full-ring positron emission tomography (FR-PET). METHODS AND
RESULTS: The performance parameters of the GC-PET system were examined and found adequate for imaging at the activity levels used clinically. We studied 15 patients who underwent stress and rest N-13-labeled NH(3) perfusion imaging on FR-PET and GC-PET systems. Quantitative analysis of perfusion values showed that GC-PET uptake was significantly lower than FR-PET uptake in 67.6% of segments. Bland-Altman analysis showed that the mean difference between FR-PET and GC-PET values was from 5.3% to 5.9%. Stress FR-PET identified 49 segments as having impaired perfusion, 46 (93.9%) of which were also identified by GC-PET. Fifty-six additional segments were identified as abnormal by GC-PET. These findings indicated a general overestimation of defect size on GC-PET. Analysis of the degree of perfusion reduction also found that GC-PET tended to overestimate defect contrast. These findings are similar to those previously found by workers examining fluorine 18-fluorodeoxyglucose uptake by both techniques.
CONCLUSIONS: Good concordance was shown between GC-PET and FR-PET systems for N-13-labeled NH(3) perfusion imaging, although further work is required to optimize the technique.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14668775     DOI: 10.1016/s1071-3581(03)00658-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  34 in total

Review 1.  PET imaging using gamma cameras.

Authors:  Y D'Asseler; S Vandenberghe; F D Winter; R Van de Walle ; M Koole; L Bouwens; I Lemahieu; R A Dierckx
Journal:  Comput Med Imaging Graph       Date:  2001 Mar-Apr       Impact factor: 4.790

Review 2.  Prognostic implications of infarct size assessed by myocardial perfusion single-photon emission tomography.

Authors:  J De Sutter; R Underwood
Journal:  Eur J Nucl Med       Date:  2000-03

3.  Clinical PET in the UK: dangers of missing an opportunity.

Authors:  M J O'Doherty
Journal:  Nucl Med Commun       Date:  2001-07       Impact factor: 1.690

4.  Determination of normal regional left ventricular function from cine-MR images using a semi-automated edge detection method.

Authors:  G D Waiter; F I McKiddie; T W Redpath; S I Semple; R J Trent
Journal:  Magn Reson Imaging       Date:  1999-01       Impact factor: 2.546

5.  Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.

Authors:  J vom Dahl; C Altehoefer; F H Sheehan; P Buechin; G Schulz; E R Schwarz; K C Koch; R Uebis; B J Messmer; U Buell; P Hanrath
Journal:  J Nucl Med       Date:  1997-05       Impact factor: 10.057

6.  Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.

Authors:  H Zhang; M Tian; N Oriuchi; T Higuchi; S Tanada; K Endo
Journal:  Br J Radiol       Date:  2002-05       Impact factor: 3.039

7.  F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.

Authors:  J Fitzgerald; J A Parker; P G Danias
Journal:  J Nucl Cardiol       Date:  2000 Jul-Aug       Impact factor: 5.952

8.  [18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?

Authors:  G Srinivasan; A N Kitsiou; S L Bacharach; M L Bartlett; C Miller-Davis; V Dilsizian
Journal:  Circulation       Date:  1998-03-10       Impact factor: 29.690

9.  Presurgical identification of hibernating myocardium by combined use of technetium-99m hexakis 2-methoxyisobutylisonitrile single photon emission tomography and fluorine-18 fluoro-2-deoxy-D-glucose positron emission tomography in patients with coronary artery disease.

Authors:  G Lucignani; G Paolini; C Landoni; M Zuccari; G Paganelli; L Galli; G Di Credico; G Vanoli; C Rossetti; M A Mariani
Journal:  Eur J Nucl Med       Date:  1992

10.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography.

Authors:  J Tillisch; R Brunken; R Marshall; M Schwaiger; M Mandelkern; M Phelps; H Schelbert
Journal:  N Engl J Med       Date:  1986-04-03       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.